Powerful antiangiogenic activity of herbimycin A (named angiostatic antibiotic).
Oikawa
T
T
Division of Cancer Therapeutics, Tokyo Metropolitan Institute of Medical Science, Japan.
Hirotani
K
K
Shimamura
M
M
Ashino-Fuse
H
H
Iwaguchi
T
T
D000482:Allantois / Q000098:blood supply*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D016227:Benzoquinones; D002196:Capillaries; D002642:Chick Embryo; D002823:Chorion / Q000098:blood supply*; D004305:Dose-Response Relationship, Drug; D005321:Extraembryonic Membranes / Q000098:blood supply*; D047029:Lactams, Macrocyclic; D009389:Neovascularization, Pathologic; D011809:Quinones / Q000494:pharmacology*; D017828:Rifabutin / Q000031:analogs & derivatives
D000900:Anti-Bacterial Agents; D016227:Benzoquinones; D047029:Lactams, Macrocyclic; D011809:Quinones; D017828:Rifabutin; C020754:herbimycin